Literature DB >> 22516834

Validation of EuroSCORE II in patients undergoing coronary artery bypass surgery.

Fausto Biancari1, Francesco Vasques, Reija Mikkola, Marta Martin, Jarmo Lahtinen, Jouni Heikkinen.   

Abstract

BACKGROUND: The European System for Cardiac Operative Risk Evaluation II (EuroSCORE II) has been recently developed to improve the performance of the original EuroSCORE. Herein we evaluated its discriminatory ability in predicting the immediate and late outcome after coronary artery bypass grafting (CABG).
METHODS: Complete data on 1,027 patients who underwent isolated CABG were available for validation of EuroSCORE II and to compare its discriminatory ability with the original EuroSCORE and its Finnish modified version.
RESULTS: EuroSCORE II performed somewhat better (area under the curve [AUC] 0.852, Brier score 0.031) than the original logistic EuroSCORE (AUC 0.838, Brier score 0.034) and its Finnish modified version (AUC 0.825, Brier score 0.034) in predicting operative mortality. The overall expected-to-observed operative mortality ratio for the original logistic EuroSCORE was 1.8, for its Finnish modified version was 0.6, and for EuroSCORE II was 1.2. EuroSCORE II showed expected-to-observed ratios ranging from 1.05 to 1.17 in its highest third quintiles. The best cutoff of EuroSCORE II in predicting operative postoperative mortality was 10% (21.5% vs 1.6%, p<0.0001; sensitivity 91.5%, specificity 60.5%, negative predictive value 98.4%, accuracy of 90.3%). The EuroSCORE II was predictive of de novo dialysis (AUC 0.805), prolonged use of inotropes (AUC 0.748), and intensive care unit stay 5 days or greater (AUC 0.793). The risk of late mortality significantly increased across increasing quintiles of EuroSCORE II (p<0.0001).
CONCLUSIONS: The EuroSCORE II performs better than its original version in predicting operative mortality and morbidity after isolated CABG. Its ability to predict 30-day mortality in high-risk patients is of particular importance. The EuroSCORE II is also a good predictor of late postoperative survival.
Copyright © 2012 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22516834     DOI: 10.1016/j.athoracsur.2012.02.064

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  28 in total

1.  Performance of EuroSCORE II compared to EuroSCORE I in predicting operative and mid-term mortality of patients from a single center after combined coronary artery bypass grafting and aortic valve replacement.

Authors:  Kyriakos Spiliopoulos; Vasilis Bagiatis; Oliver Deutsch; Bernhard M Kemkes; Nikolaos Antonopoulos; Dimos Karangelis; Ayman Haschemi; Brigitte Gansera
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-08-29

2.  Prediction of long-term mortality in ICU patients: model validation and assessing the effect of using in-hospital versus long-term mortality on benchmarking.

Authors:  Sylvia Brinkman; Ameen Abu-Hanna; Evert de Jonge; Nicolette F de Keizer
Journal:  Intensive Care Med       Date:  2013-08-07       Impact factor: 17.440

3.  GNAS gene variants affect β-blocker-related survival after coronary artery bypass grafting.

Authors:  Ulrich H Frey; Jochen D Muehlschlegel; Jürgen Peters; Simon Body; Christoph Ochterbeck; Amanda A Fox; Stanton K Shernan; Charles D Collard; Peter Lichtner
Journal:  Anesthesiology       Date:  2014-05       Impact factor: 7.892

4.  Predictive value of high-sensitivity troponin T in addition to EuroSCORE II in cardiac surgery.

Authors:  Liisa Petäjä; Helge Røsjø; Leena Mildh; Raili Suojaranta-Ylinen; Kirsi-Maija Kaukonen; Janne J Jokinen; Markku Salmenperä; Tor-Arne Hagve; Torbjørn Omland; Ville Pettilä
Journal:  Interact Cardiovasc Thorac Surg       Date:  2016-03-16

5.  Emergency Coronary Artery Bypass Grafting: Indications and Outcomes from 2003 through 2013.

Authors:  Erin M Schumer; John H Chaney; Jaimin R Trivedi; Paul L Linsky; Matthew L Williams; Mark S Slaughter
Journal:  Tex Heart Inst J       Date:  2016-06-01

6.  [ESC/EACTS guidelines on myocardial revascularization : Amendments 2014].

Authors:  H Nef; M Renker; C W Hamm
Journal:  Herz       Date:  2014-12       Impact factor: 1.443

7.  Evaluation of two-dimensional strain echocardiography for quantifying right ventricular function in patients with pulmonary arterial hypertension.

Authors:  Yong Liu; Yong Wang; Yingying Wang; Zhe Wen
Journal:  Exp Ther Med       Date:  2017-06-12       Impact factor: 2.447

8.  Postoperative Outcome of High-Risk Octogenarians Undergoing Cardiac Surgery: A Multicenter Observational Retrospective Study.

Authors:  Michal Porizka; Jan Kunstyr; Tomas Vanek; Michal Nejedly; Jana Buckova; Jiri Mokrejs; Frantisek Mosna
Journal:  Ann Thorac Cardiovasc Surg       Date:  2017-05-24       Impact factor: 1.520

9.  Early and Medium Outcomes of On-Pump Beating-Heart versus Off-Pump CABG in Patients with Moderate Left Ventricular Dysfunction.

Authors:  Weitie Wang; Yong Wang; Hulin Piao; Bo Li; Tiance Wang; Dan Li; Zhicheng Zhu; Rihao Xu; Kexiang Liu
Journal:  Braz J Cardiovasc Surg       Date:  2019 Jan-Feb

10.  Comparison of contemporary risk scores for predicting outcomes after surgery for active infective endocarditis.

Authors:  Tom Kai Ming Wang; Timothy Oh; Jamie Voss; Greg Gamble; Nicholas Kang; James Pemberton
Journal:  Heart Vessels       Date:  2014-01-25       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.